NCT00006340View on ClinicalTrials.gov

Ganciclovir Plus Arginine Butyrate in Treating Patients With Cancer or Lymphoproliferative Disorders Associated With the Epstein Barr Virus

PHASE1CompletedINTERVENTIONAL
Timeline

Start Date

December 31, 1994

Primary Completion Date

July 31, 2000

Study Completion Date

July 31, 2000

Conditions
LeukemiaLymphomaPrecancerous ConditionSmall Intestine Cancer
Interventions
DRUG

arginine butyrate

DRUG

ganciclovir

Trial Locations (6)

10021

Memorial Sloan-Kettering Cancer Center, New York

20133

Istituto Nazionale per lo Studio e la Cura dei Tumori, Milan

46202

Methodist Cancer Center at Methodist Hospital, Indianapolis

75743

Hopital Necker, Paris

02118

Cancer Research Center at Boston Medical Center, Boston

D-30625

Medizinische Hochschule Hannover, Hanover

Sponsors
All Listed Sponsors
lead

Boston Medical Center

OTHER